A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation
- PMID: 19680431
- PMCID: PMC2715216
- DOI: 10.1371/journal.pcbi.1000458
A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation
Abstract
Nanoparticles introduced in living cells are capable of strongly promoting the aggregation of peptides and proteins. We use here molecular dynamics simulations to characterise in detail the process by which nanoparticle surfaces catalyse the self-assembly of peptides into fibrillar structures. The simulation of a system of hundreds of peptides over the millisecond timescale enables us to show that the mechanism of aggregation involves a first phase in which small structurally disordered oligomers assemble onto the nanoparticle and a second phase in which they evolve into highly ordered as their size increases.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
microseconds, the peptides are in their monomeric state. (B) At intermediate times,
milliseconds, small oligomeric assemblies form on the nanoparticle surface. (C) At later times,
milliseconds, these oligomers re-order into fibrillar structures as their size increases. Peptides that do not form intermolecular hydrogen bonds are shown in blue, while peptides that form intermolecular hydrogen bonds are assigned a random colour, which is the same for peptides that belong to the same
. Two peptides are defined as belonging to the same cluster if their centres of mass distance is less than 5 Å. Two peptides are taken to participate within a
if they form more than four inter-chain hydrogen bonds with each other. The spherical nanoparticle is displayed in orange in the centre of the simulation box; the diameter of the peptides is slightly reduced for illustration purposes. Panels (B) and (C) show enlarged views of the nanoparticle-peptide system. The simulation was performed at
,
,
, and
.
observed during a simulation in presence of a hard sphere nanoparticle:
,
(green line), and several hydrophobic nanoparticles that differ in diameter and hydrophobicity:
,
(blue line),
,
(red line), and
,
(black line). The results are averaged over ten independent simulation runs and the error bars correspond to the standard deviation of the mean. (B) Number of clusters
of size
as a function of time:
microseconds (left),
milliseconds (middle),
milliseconds (right), for the MD trajectory and parameters described in Fig. 1. Black lines correspond to all clusters formed in the system; red lines correspond to the number of clusters formed on the nanoparticle surface. (C) Structural order parameter
as a function of the cluster size
averaged over ten independent simulations. The line colours are as described in (A). (D) Normalized density profile
, where
is the bulk density of the system, as a function of the distance from the centre of mass of the nanoparticle at the beginning of the simulation,
microseconds (left panel), intermediate times,
milliseconds (middle panel), and at the end
milliseconds (right panel). The different line colours are as described in (A) and correspond to the different seed sizes and peptide seed interaction energies. The results are averaged over ten independent simulations and the error bars correspond to the standard deviation of the mean.
,
at
microseconds(left),
milliseconds (middle),
milliseconds (right). (B)
,
at
microseconds (left),
milliseconds (middle),
milliseconds (right). The concentration and temperature are
,
respectively, and the colour code is as described in Fig 1.
and
between
atoms
and
used to define a
helical hydrogen bond assigned to atoms
with
. (B) Histogram of distances
between
atoms
that form a parallel, anti-parallel, or helical hydrogen bond. For the
helical hydrogen bond
. (C) Illustration of the alternation of distances for consecutive
atoms that form anti-parallel hydrogen bonds. (D) as in (C). (E) The distance
is used to define hydrogen bonds between atoms
in parallel and anti parallel
. (F) Distances used to define cooperative hydrogen bonds between two consecutive atoms
and
that form parallel
or
and
that form anti parallel
.References
-
- Fischer HC, Chan WCW. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotech. 2007;18:565–571. - PubMed
-
- Lynch I, Dawson KA. Protein-nanoparticle interactions. Nano Today. 2008;3:40–47.
-
- Schulze C, Kroll A, Lehr CM, Schafer UF, Becker K, et al. Not ready to use – overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology. 2008;2:51–61.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
